Morpholine-like monoamine releasers
Grant
US12595269B2
Kind: B2
Apr 07, 2026
Assignee
Solvonis Therapeutics Ireland Holdings Limited
Inventors
Alan Borthwick, Fabrizio Micheli, Alessandra Micoli, Ferruccio Palazzesi, Agostino Cianciulli, Robin Tyacke, David Nutt
Abstract
Disclosed herein are certain therapeutic substituted heterocyclic bridged ring compounds, including substituted morpholine, thiomorpholine, and piperidine compounds and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such compounds, and methods of their use to treat mental health disorders and CNS disorders.
CPC Classifications
A61K 31/407
Filing Date
2023-02-16
Application No.
18838986
Claims
20